Insider trading

Period: 120 months Stock: KURA Plan: Discretionary × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

40 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

40 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

40 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

40 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
40 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
40 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

40 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
29 Sep 2026
Leoni Mollie Chief Medical Officer
Sold at will
$309.57K 28,802 at 10.75
17.0%
Not planned
29 Sep 2026
Powl Brian T. Chief Commercial Officer
Sold at will
$165.85K 15,430 at 10.75
10.1%
Not planned
28 Sep 2026
Powl Brian T. Chief Commercial Officer
Sold at will 2×
$179.18K 17,020 at 10.53
10.1%
Not planned
28 Sep 2026
Leoni Mollie Chief Medical Officer
Sold at will
$130.67K 12,448 at 10.50
6.8%
Not planned
28 Sep 2026
DOYLE THOMAS JAMES SVP, Finance & Accounting
Sold at will
$48.36K 4,607 at 10.50
3.1%
Not planned
24 Sep 2026
Burrows Francis Chief Scientific Officer
Sold at will
$224.51K 20,726 at 10.83
32.9%
Not planned
24 Aug 2026
WILSON TROY EDWARD President and CEO · indirect
Bought
$1.24M 100,000 at 12.39
26.4%
Largest buy in 3 yrs
17 Aug 2026
WILSON TROY EDWARD President and CEO · indirect
Bought
$1.11M 100,000 at 11.12
35.8%
Largest buy in 3 yrs
27 Jan 2026
Bair Teresa Brophy Chief Legal Officer
Sold at will 3×
$94.83K 11,208 at 8.46
4.7%
Not planned
27 Jan 2026
Leoni Mollie Chief Medical Officer
Sold at will 4×
$69.21K 8,180 at 8.46
3.0%
Not planned
27 Jan 2026
DOYLE THOMAS JAMES SVP, Finance & Accounting
Sold at will 5×
$60.43K 7,142 at 8.46
4.7%
Not planned
27 Jan 2026
Powl Brian T. Chief Commercial Officer
Sold at will 2×
$54.27K 6,414 at 8.46
3.4%
Not planned
27 Jan 2026
FORD KATHLEEN Chief Operating Officer
Sold at will
$15.34K 1,813 at 8.46
1.2%
Not planned
27 Jan 2026
Burrows Francis Chief Scientific Officer
Sold at will
$11.09K 1,311 at 8.46
3.9%
Not planned
18 Dec 2025
Burrows Francis Chief Scientific Officer
Sold at will
$231.93K 23,726 at 9.78
41.3%
Not planned
9 Dec 2025
Hasnain Faheem Director
Sold at will
$109.76K 10,000 at 10.98
29.4%
Not planned
14 Nov 2025
Leoni Mollie Chief Medical Officer
Sold at will
$173.07K 15,485 at 11.18
6.4%
Not planned
14 Nov 2025
Powl Brian T. Chief Commercial Officer
Sold at will
$99.33K 8,887 at 11.18
6.0%
Not planned
14 Nov 2025
DOYLE THOMAS JAMES SVP, Finance & Accounting
Sold at will
$50.73K 4,539 at 11.18
3.4%
Not planned
29 Sep 2025
WILSON TROY EDWARD President and CEO
Sold at will
$327.42K 36,615 at 8.94
12.9%
Not planned
29 Sep 2025
Leoni Mollie Chief Medical Officer
Sold at will
$110.11K 12,314 at 8.94
7.2%
Not planned
29 Sep 2025
Powl Brian T. Chief Commercial Officer
Sold at will
$79.51K 8,891 at 8.94
8.2%
Not planned
29 Sep 2025
DOYLE THOMAS JAMES SVP, Finance & Accounting
Sold at will
$40.61K 4,541 at 8.94
4.0%
Not planned
8 Sep 2025
WILSON TROY EDWARD President & CEO
Bought
$410.15K 50,000 at 8.20
98.1%
Largest buy in 3 yrs
13 Aug 2025
WILSON TROY EDWARD President and CEO
Bought
$89.62K 13,494 at 6.64
36.0%
+36% of stake
12 Aug 2025
WILSON TROY EDWARD President and CEO
Bought
$213.58K 36,506 at 5.85
×38
First buy on file
21 Mar 2025
Hasnain Faheem Director
Sold at will
$181.46K 22,682 at 8.00
48.6%
Not planned
28 Jan 2025
Bair Teresa Brophy Chief Legal Officer
Sold at will 2×
$57.32K 7,281 at 7.87
6.3%
Not planned
28 Jan 2025
Leoni Mollie Chief Medical Officer
Sold at will 4×
$39.07K 4,963 at 7.87
5.3%
Not planned
28 Jan 2025
DOYLE THOMAS JAMES SVP, Finance & Accounting
Sold at will 4×
$38.96K 4,949 at 7.87
5.3%
Not planned
28 Jan 2025
Burrows Francis Chief Scientific Officer
Sold at will 2×
$17.05K 2,166 at 7.87
9.5%
Not planned
28 Jan 2025
FORD KATHLEEN Chief Operating Officer
Sold at will
$14.30K 1,817 at 7.87
7.8%
Not planned
28 Jan 2025
Powl Brian T. Chief Commercial Officer
Sold at will
$12.46K 1,583 at 7.87
2.6%
Not planned
30 Jan 2024
DALE STEPHEN Chief Medical Officer
Sold at will
$103.98K 4,825 at 21.55
11.1%
Not planned
29 Jan 2024
DALE STEPHEN Chief Medical Officer
Sold at will 2×
$127.42K 7,158 at 17.80
14.1%
Not planned
29 Jan 2024
DOYLE THOMAS JAMES SVP, Finance & Accounting
Sold at will 3×
$41.26K 2,318 at 17.80
4.6%
Not planned
29 Jan 2024
Bair Teresa Brophy Chief Legal Officer
Sold at will
$36.54K 2,053 at 17.80
2.9%
Not planned
29 Jan 2024
FORD KATHLEEN Chief Operating Officer
Sold at will
$26.63K 1,496 at 17.80
6.5%
Not planned
24 Jan 2024
WILSON TROY EDWARD President and CEO
Sold at will 2×
$1.84M 91,052 at 20.23
99.4%
Sold half or more
16 Jun 2023
Malley Thomas Director · indirect
Bought
$575.00K 50,000 at 11.50
55.8%
First buy on file
Showing 1–40 of 40.